In this episode of the EY Health Sciences and Wellness Experience Podcast, Aloha McBride and her guests explore health inequity, sustainable change and environmental impact of the health industry.   Our panel of experts discuss the evolution of sustainability in health. The explore where organizations can start on their sustainability journey, how they can create sustainable change, and reduce climate impact. Through exploring global examples. they show how data and analytics play a key role in long-term strategies and regulatory compliance. Join in and discover the steps to lessen environmental impact, leverage data for sustainability, and form valuable partnerships. Drive behaviour change, avoid inaction risks, and embark on a transformative sustainability journey in healthcare.    

In today's episode we focus on the EY report on the Pharma supply chains of the future, and discuss the impact of global events and how a new supply chain model can emerge in the pharma industry.   The speakers discuss the future of pharmaceutical supply chains in the wake of the COVID-19 pandemic and other geopolitical events and shifts that are unfolding around us. The discussion covers the impact of global events that have led to a revaluation of globalized supply chain models and a creation of a new, optimised model where the end-to-end visibility is a crucial factor. Join us as we explore the future of pharmaceutical supply chains and their adaptability in the face of challenges.

In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact.   Together they review the growing importance of sustainable health solutions, ESG in healthcare and sustainability reporting in the Health Sciences and Wellness industry. Learn how ESG reporting and the information flow that helps businesses successfully engage with their stakeholders.   The conversation also explores global use cases, the significance of banking for impact, and the gaps in impact measurement that need attention in the coming years. Uncover the multitude of metrics available in sustainability reporting, the growing importance of sustainability metrics, and their potential to drive transformative conversations.

In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson Corporation and look into innovation in healthcare and health care data science.   They discuss the unique complexities of healthcare – a sector with new entrants, new regulations, consolidation, pricing pressures, and an ageing population that needs ever more healthcare. But alongside the complexities, there are opportunities for disruptive innovation as well as technology and data.   The conversation also covers the challenge of recruiting and retaining data scientists and how to connect their skills and talents to patient health outcomes. Finally, they discuss the excitement and importance of using technology and data to support healthcare and the quality of patients' lives.

In this episode of the EY Health Sciences and Wellness Experience podcast we focus on women in health. Join Pamela Spence, EY Global Health Sciences and Wellness Leader, as she speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Khan, Founder/CEO, Ladder Therapeutics, and Samin Saeed, UK Chief Scientific Officer and Medical Director, Novartis.   Together they discuss their own unique career journeys within the health sciences and wellness industry. They also share with us those critical lessons they have learned from their mentors and supporters along the way. They offer valuable insights on med-tech innovations, diversity in tech and in med-tech companies, changes in the medical sector. This inspiring dialogue challenges us to reflect on our own experiences and ask ourselves, "Are we doing enough to foster the next generation of leaders?" Tune in and be inspired by the incredible female leadership present in the industry today.

In this episode of the EY Health Sciences and Wellness Experience Podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, Jackie Hunter, Board Director of Benevolent AI and Ridwaan Jhetam, VP Global Medical for Haematology, BMS, discuss the importance of data science in healthcare and how it can help redesign the health experience and the future of health.   In this wide-ranging discussion, the expert panel approach the topic of health economy and smart health from their different perspectives. Whether you’re a doctor or researcher, a programmer or a CIO, whether you work in the field or you’re just looking in from outside, you’ll find this an insightful and timely listen.

There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. As the evolution of medicine continues, the future looks promising for advancements in cell and gene therapy.   In this podcast, Adlai Goldberg, Global Digital, Social and Commercial Innovation Life Sciences Leader for EY, talks to Tamie Joeckel – ICON’s Cell and Gene Therapy Global Business Lead, as they discuss the use of technology in medicine and what makes an increase in the volume of clinical trials, including cgt clinical trials, and an acceleration of the clinical trial process significant.

In this episode, we delve into the global challenge of addressing health inequality with Dr. Yele Aluko, EY Chief Medical Officer, and Dr. David Rhew, Microsoft Chief Medical Officer. As experienced physicians, they share their passion for finding opportunities to provide health equity and discuss the root causes of disparities and how unbiased digital medicine can help.   We learn that health care disparity starts much earlier than diagnosis and treatment, with low minority enrolment rates in clinical trials leading to results that don't reflect the population. The COVID-19 pandemic has highlighted health disparities across populations, and we need strategic insight from the health care value chain to identify healthcare gap and develop tactics and solutions that will close them.   Join us as we discuss the evolution of medicine, the importance of inclusive clinical trials, and how digital solutions can help us close the healthcare gap.

In this first episode of our EY Health Sciences and Wellness Experience podcast series, we explore the emerging and much needed age of “Health Experience” and the disruptive health innovation emerging in the aftermath of the covid 19 pandemic.   The Covid 19 impact on healthcare was immense and Health Sciences and Wellness industry has never been as “front and centre” in our lives as it has been in this last year. As all of us, worldwide, ride the various waves of the pandemic, our Health Sciences and Wellness industry has taken the lead in healthcare analytics and healthcare innovation and giving care to those who have needed it most. We have also seen a monumental collaborative R&D effort – at a scale never witnessed before.   Tune in as we explore the various trends in healthcare innovation, technology and analytics that are reshaping the Health Sciences and Wellness Industry and driving the evolution of the smart health systems of the future that can deliver an improved Health Experience.